» Articles » PMID: 23485712

Hemodynamic Flow Improves Rat Hepatocyte Morphology, Function, and Metabolic Activity in Vitro

Overview
Specialties Cell Biology
Physiology
Date 2013 Mar 15
PMID 23485712
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

In vitro primary hepatocyte systems typically elicit drug induction and toxicity responses at concentrations much higher than corresponding in vivo or clinical plasma C(max) levels, contributing to poor in vitro-in vivo correlations. This may be partly due to the absence of physiological parameters that maintain metabolic phenotype in vivo. We hypothesized that restoring hemodynamics and media transport would improve hepatocyte architecture and metabolic function in vitro compared with nonflow cultures. Rat hepatocytes were cultured for 2 wk either in nonflow collagen gel sandwiches with 48-h media changes or under controlled hemodynamics mimicking sinusoidal circulation within a perfused Transwell device. Phenotypic, functional, and metabolic parameters were assessed at multiple times. Hepatocytes in the devices exhibited polarized morphology, retention of differentiation markers [E-cadherin and hepatocyte nuclear factor-4α (HNF-4α)], the canalicular transporter [multidrug-resistant protein-2 (Mrp-2)], and significantly higher levels of liver function compared with nonflow cultures over 2 wk (albumin ~4-fold and urea ~5-fold). Gene expression of cytochrome P450 (CYP) enzymes was significantly higher (fold increase over nonflow: CYP1A1: 53.5 ± 10.3; CYP1A2: 64.0 ± 15.1; CYP2B1: 15.2 ± 2.9; CYP2B2: 2.7 ± 0.8; CYP3A2: 4.0 ± 1.4) and translated to significantly higher basal enzyme activity (device vs. nonflow: CYP1A: 6.26 ± 2.41 vs. 0.42 ± 0.015; CYP1B: 3.47 ± 1.66 vs. 0.4 ± 0.09; CYP3A: 11.65 ± 4.70 vs. 2.43 ± 0.56) while retaining inducibility by 3-methylcholanthrene and dexamethasone (fold increase over DMSO: CYP1A = 27.33 and CYP3A = 4.94). These responses were observed at concentrations closer to plasma levels documented in vivo in rats. The retention of in vivo-like hepatocyte phenotype and metabolic function coupled with drug response at more physiological concentrations emphasizes the importance of restoring in vivo physiological transport parameters in vitro.

Citing Articles

Liver-on-chips for drug discovery and development.

Mehta V, Karnam G, Madgula V Mater Today Bio. 2024; 27:101143.

PMID: 39070097 PMC: 11279310. DOI: 10.1016/j.mtbio.2024.101143.


Human cardiovascular disease model predicts xanthine oxidase inhibitor cardiovascular risk.

Feaver R, Bowers M, Cole B, Hoang S, Lawson M, Taylor J PLoS One. 2023; 18(9):e0291330.

PMID: 37682977 PMC: 10490929. DOI: 10.1371/journal.pone.0291330.


Design, Simulation, and Evaluation of Polymer-Based Microfluidic Devices via Computational Fluid Dynamics and Cell Culture "On-Chip".

Bakuova N, Toktarkan S, Dyussembinov D, Azhibek D, Rakhymzhanov A, Kostas K Biosensors (Basel). 2023; 13(7).

PMID: 37504152 PMC: 10377015. DOI: 10.3390/bios13070754.


Microneedle array facilitates hepatic sinusoid construction in a large-scale liver-acinus-chip microsystem.

Li S, Li C, Khan M, Liu J, Shi Z, Gao D Microsyst Nanoeng. 2023; 9:75.

PMID: 37303831 PMC: 10247758. DOI: 10.1038/s41378-023-00544-w.


A comprehensive overview of advanced dynamic intestinal and hepatic cell culture models.

Leal F, Zeiringer S, Jeitler R, Costa P, Roblegg E Tissue Barriers. 2023; 12(1):2163820.

PMID: 36680530 PMC: 10832944. DOI: 10.1080/21688370.2022.2163820.


References
1.
Wambaugh J, Shah I . Simulating microdosimetry in a virtual hepatic lobule. PLoS Comput Biol. 2010; 6(4):e1000756. PMC: 2858695. DOI: 10.1371/journal.pcbi.1000756. View

2.
Kasuya J, Sudo R, Mitaka T, Ikeda M, Tanishita K . Spatio-temporal control of hepatic stellate cell-endothelial cell interactions for reconstruction of liver sinusoids in vitro. Tissue Eng Part A. 2012; 18(9-10):1045-56. DOI: 10.1089/ten.TEA.2011.0351. View

3.
Landry J, Bernier D, Ouellet C, Goyette R, Marceau N . Spheroidal aggregate culture of rat liver cells: histotypic reorganization, biomatrix deposition, and maintenance of functional activities. J Cell Biol. 1985; 101(3):914-23. PMC: 2113699. DOI: 10.1083/jcb.101.3.914. View

4.
Gomez-Lechon M, Castell J, Donato M . The use of hepatocytes to investigate drug toxicity. Methods Mol Biol. 2010; 640:389-415. DOI: 10.1007/978-1-60761-688-7_21. View

5.
Zhang J, Ho T, Callendrello A, Crespi C, Stresser D . A multi-endpoint evaluation of cytochrome P450 1A2, 2B6 and 3A4 induction response in human hepatocyte cultures after treatment with β-naphthoflavone, phenobarbital and rifampicin. Drug Metab Lett. 2010; 4(4):185-94. DOI: 10.2174/187231210792928224. View